文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Crystal Williams
发表
Outcomes According to ALK Status Determined by Central Immunohistochemistry or Fluorescence In Situ Hybridization in Patients With ALK-Positive NSCLC Enrolled in the Phase 3 ALEX Study.
A. Shaw, S. Ou, T. Mok, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.